Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
about
P1343
Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malariaIdentification of cellular genes targeted by KSHV-encoded microRNAsThe tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migrationKSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfateIntegrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptorKaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathwayHuman herpesvirus 8--a novel human pathogenViral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cellsIdentification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirusIdentification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localizationNucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection.Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinomaThe 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigenEpstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiationDelta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitroGene expression profile of AIDS-related Kaposi's sarcomaUse of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysisDevelopment of a real-time QPCR assay for the detection of RV2 lineage-specific rhadinoviruses in macaques and baboonsActivation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes VirusNext-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) BiologyOncogenes and RNA splicing of human tumor virusesThe conundrum of causality in tumor virology: the cases of KSHV and MCVCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsMono-ubiquitylated ORF45 Mediates Association of KSHV Particles with Internal Lipid Rafts for Viral Assembly and EgressKaposi's sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid-tegument complexes along microtubulesEnhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirusInhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomersMolecular Approaches to the Identification of Unculturable Infectious AgentsKSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane DynamicsMulti-step regulation of innate immune signaling by Kaposi's sarcoma-associated herpesvirusThe Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesKSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaMolecular virology of Kaposi's sarcoma-associated herpesvirusAntiviral drug susceptibility of human herpesvirus 8Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.Control of Kaposi's sarcoma-associated herpesvirus reactivation induced by multiple signals
P2860
Q21131129-CB925EDC-4A41-4F19-9B41-2F746D50E352Q21131610-B0980C6F-3715-4F8A-9654-C0AE12E25F78Q21146664-1B6E7CDB-A284-49AA-89EA-48131CF6F74DQ24301376-8604FC3E-31D8-4F38-901C-3D3CFFEA0AEEQ24301712-A9DF4B4A-1C66-4C72-87A8-F1858C3A02A0Q24316207-8507D172-9BE8-4D71-89EA-E85F8ABD046AQ24530670-FDF6879E-FA4C-47A4-8470-87B5A0CC9DF6Q24538223-D72F18F0-F5C6-4163-AB4F-C89A1BCB83A4Q24543014-C73243D1-B66B-4075-A92C-F6D3A1353814Q24555724-388C9295-E456-4AB4-9045-8D00A1BE950CQ24561400-290613B1-A0FD-4729-BA4D-DA879B82E4D2Q24648127-A28F89FA-307B-4087-932C-923248CC4117Q24650427-BD664910-C43E-4560-AEA3-971F2980DD55Q24670607-732BBE83-CBAF-4D9A-911C-89BE3BE3CC27Q24671700-2DD8ED30-7558-4FC1-97AB-F9F7609234F0Q24672438-CC32AEBB-766D-4646-A472-3D6E34118E49Q24678677-AE4EE22A-3B1C-4038-B705-2BCC70CB3929Q24797076-CD5170E6-E6CC-421D-9FB2-FDD051271546Q24797857-E3BE015B-27C5-49D2-9372-9F6B6C9C9399Q24799552-9353CF75-9092-48FB-9945-41BF04022425Q24803503-6B7BF3C5-56BB-4766-9A76-D7246A9332B0Q26743368-836DC6B8-EA2E-4381-84F5-4D4B8DD0C6B6Q26752599-85FA8037-6CBB-47DA-A69C-BD1FEF03744AQ26830643-C6EFE457-9085-4193-9883-4C51F8D80652Q26863112-E0596824-42AA-40B2-88A7-079A38FA6B12Q27023452-84FEFB09-D021-4DAE-9179-96412E9BB274Q27316661-7207B3C2-6C22-4F3D-AB27-23CBA7263F05Q27317383-402221A1-1EE4-402C-94A0-EC355A83C9A9Q27318672-4FF9C70F-487B-4783-A608-FB69AF139DB7Q27486045-DDD94356-02B9-407D-8A3E-257C61097ACBQ27486093-A4039C8B-832A-47E0-A810-109A9289C890Q27487576-3A8CFC38-0BA6-44A0-83C4-2229FEA0E5F2Q28072153-49149F79-E550-4367-95A3-39A650F8BD80Q28080550-E3982918-65DD-4187-9F54-2F229717B597Q28271798-33EBDAEC-44E0-4FD8-ABFC-161FA747637EQ28284765-2CB97CD0-4CAF-45E6-B981-EDED1A5BA12EQ28363323-00794C1D-272D-457A-A475-EC3779FFC5E5Q28379288-934D8782-1040-4053-8053-5CEF89E45114Q28476740-B28E672C-C449-4AB9-B364-CA67D7E56483Q28478842-0A8257F1-E090-4052-B490-23B04191D072
P2860
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
@en
type
label
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
@en
prefLabel
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
@en
P2093
P2860
P356
P1433
P1476
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
@en
P2093
P2860
P2888
P304
P356
10.1038/NM0396-342
P407
P4510
P50
P577
1996-03-01T00:00:00Z